Skip to main content
Erschienen in: Child's Nervous System 5/2008

01.05.2008 | Original Paper

The impact of antibiotic-impregnated catheters on shunt infection in children and neonates

verfasst von: Caroline Hayhurst, Richard Cooke, Dawn Williams, Jothy Kandasamy, Donncha F. O’Brien, Conor L. Mallucci

Erschienen in: Child's Nervous System | Ausgabe 5/2008

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Infection remains a significant problem with cerebrospinal fluid (CSF) diversion procedures. Antibiotic-impregnated shunt catheters (AIS) have been introduced to prevent infection, mainly in the early post-operative period when most infections occur. We evaluate the impact on infection rates in children following the introduction of catheters impregnated with rifampicin and clindamycin.

Materials and methods

The study was a retrospective analysis of all paediatric shunt procedures undertaken after the introduction of AIS systems in 2003. All procedures where a complete AIS system was implanted were included. For the purpose of analysis, shunt procedures were classified as de novo (group 1), clean revision (group 2) and following external ventricular drainage with either sterile CSF (group 3) or infected CSF (group 4). Results were compared to a historical cohort of shunt procedures undertaken before the introduction of AIS catheters.

Results

A total of 214 AIS were implanted in 150 children between October 2003 and December 2006. There were 4 infections in group 1 (8.5%), 6 infections in group 2 (5.3%) and 11 infections in groups 3 and 4 (20%). The historical control group comprised 77 shunts in 65 children. The infection rate in neonatal de novo shunts reduced from 27 to 10.4% following the introduction of AIS catheters.

Conclusions

AIS catheters can reduce the number of shunt infections seen in clinical practice in certain subgroups. This has had a significant impact on the neonatal hydrocephalic population. The high risk of shunt infection after a period of external ventricular drainage raises the issue of emergence of bacterial resistance.
Literatur
1.
Zurück zum Zitat Aryan HE, Meltzer HS, Park MS, Bennett RL, Jandial R, Levy ML (2005) Initial experience with antibiotic-impregnated silicone catheters for shunting of cerebrospinal fluid in children. Childs Nerv Syst 21:56–61PubMedCrossRef Aryan HE, Meltzer HS, Park MS, Bennett RL, Jandial R, Levy ML (2005) Initial experience with antibiotic-impregnated silicone catheters for shunting of cerebrospinal fluid in children. Childs Nerv Syst 21:56–61PubMedCrossRef
2.
Zurück zum Zitat Bayston R (1989) Hydrocephalus shunt infections. Chapman and Hall, London Bayston R (1989) Hydrocephalus shunt infections. Chapman and Hall, London
3.
Zurück zum Zitat Bayston R, Grove N, Siegel J, Lawellin D, Barsham S (1989) Prevention of hydrocephalus shunt catheter colonisation in vitro by impregnation with antimicrobials. J Neurol Neurosurg Psychiatry 52:605–609PubMed Bayston R, Grove N, Siegel J, Lawellin D, Barsham S (1989) Prevention of hydrocephalus shunt catheter colonisation in vitro by impregnation with antimicrobials. J Neurol Neurosurg Psychiatry 52:605–609PubMed
4.
Zurück zum Zitat Bayston R, Lambert E (1997) Duration of protective activity of cerebrospinal fluid shunt catheters impregnated with antimicrobial agents to prevent bacterial catheter-related infection. J Neurosurg 87:247–251PubMed Bayston R, Lambert E (1997) Duration of protective activity of cerebrospinal fluid shunt catheters impregnated with antimicrobial agents to prevent bacterial catheter-related infection. J Neurosurg 87:247–251PubMed
5.
Zurück zum Zitat Bayston R, Ashraf W, Bhundia C (2004) Mode of action of an antimicrobial biomaterial for use in hydrocephalus shunts. J Antimicrob Chemother 53:778–782PubMedCrossRef Bayston R, Ashraf W, Bhundia C (2004) Mode of action of an antimicrobial biomaterial for use in hydrocephalus shunts. J Antimicrob Chemother 53:778–782PubMedCrossRef
6.
Zurück zum Zitat Borgbjerg BM, Gjerris F, Albeck MJ, Borgesen SE (1995) Risk of infection after cerebrospinal fluid shunt: an analysis of 884 first-time shunts. Acta Neurochir (Wien) 136:1–7CrossRef Borgbjerg BM, Gjerris F, Albeck MJ, Borgesen SE (1995) Risk of infection after cerebrospinal fluid shunt: an analysis of 884 first-time shunts. Acta Neurochir (Wien) 136:1–7CrossRef
7.
Zurück zum Zitat Choux M, Genitori L, Lang D, Lena G (1992) Shunt implantation: reducing the incidence of shunt infection. J Neurosurg 77:875–880PubMed Choux M, Genitori L, Lang D, Lena G (1992) Shunt implantation: reducing the incidence of shunt infection. J Neurosurg 77:875–880PubMed
8.
Zurück zum Zitat Drake JM, Sainte-Rose C (1995) The Shunt book. Blackwell Science, Cambridge, Mass Drake JM, Sainte-Rose C (1995) The Shunt book. Blackwell Science, Cambridge, Mass
9.
Zurück zum Zitat Enger PO, Svendsen F, Wester K (2003) CSF shunt infections in children: experiences from a population-based study. Acta Neurochir (Wien) 145:243–248 discussion 248CrossRef Enger PO, Svendsen F, Wester K (2003) CSF shunt infections in children: experiences from a population-based study. Acta Neurochir (Wien) 145:243–248 discussion 248CrossRef
10.
Zurück zum Zitat Fan-Havard P, Nahata MC (1987) Treatment and prevention of infections of cerebrospinal fluid shunts. Clin Pharm 6:866–880PubMed Fan-Havard P, Nahata MC (1987) Treatment and prevention of infections of cerebrospinal fluid shunts. Clin Pharm 6:866–880PubMed
11.
Zurück zum Zitat Govender ST, Nathoo N, van Dellen JR (2003) Evaluation of an antibiotic-impregnated shunt system for the treatment of hydrocephalus. J Neurosurg 99:831–839PubMed Govender ST, Nathoo N, van Dellen JR (2003) Evaluation of an antibiotic-impregnated shunt system for the treatment of hydrocephalus. J Neurosurg 99:831–839PubMed
12.
Zurück zum Zitat Kan P, Kestle J (2007) Lack of efficacy of antibiotic-impregnated shunt systems in preventing shunt infections in children. Childs Nerv Syst 23:773–777PubMedCrossRef Kan P, Kestle J (2007) Lack of efficacy of antibiotic-impregnated shunt systems in preventing shunt infections in children. Childs Nerv Syst 23:773–777PubMedCrossRef
13.
Zurück zum Zitat Kulkarni AV, Drake JM, Lamberti-Pasculli M (2001) Cerebrospinal fluid shunt infection: a prospective study of risk factors. J Neurosurg 94:195–201PubMed Kulkarni AV, Drake JM, Lamberti-Pasculli M (2001) Cerebrospinal fluid shunt infection: a prospective study of risk factors. J Neurosurg 94:195–201PubMed
14.
Zurück zum Zitat Pattavilakom A, Kotasnas D, Korman TM, Xenos C, Danks A (2006) Duration of in vivo antimicrobial activity of antibiotic-impregnated cerebrospinal fluid catheters. Neurosurgery 58:930–935 discussion 930–935PubMedCrossRef Pattavilakom A, Kotasnas D, Korman TM, Xenos C, Danks A (2006) Duration of in vivo antimicrobial activity of antibiotic-impregnated cerebrospinal fluid catheters. Neurosurgery 58:930–935 discussion 930–935PubMedCrossRef
15.
Zurück zum Zitat Pople IK, Bayston R, Hayward RD (1992) Infection of cerebrospinal fluid shunts in infants: a study of etiological factors. J Neurosurg 77:29–36PubMed Pople IK, Bayston R, Hayward RD (1992) Infection of cerebrospinal fluid shunts in infants: a study of etiological factors. J Neurosurg 77:29–36PubMed
16.
Zurück zum Zitat Ronan A, Hogg GG, Klug GL (1995) Cerebrospinal fluid shunt infections in children. Pediatr Infect Dis J 14:782–786PubMed Ronan A, Hogg GG, Klug GL (1995) Cerebrospinal fluid shunt infections in children. Pediatr Infect Dis J 14:782–786PubMed
17.
Zurück zum Zitat Schiff SJ, Oakes WJ (1989) Delayed cerebrospinal-fluid shunt infection in children. Pediatr Neurosci 15:131–135PubMedCrossRef Schiff SJ, Oakes WJ (1989) Delayed cerebrospinal-fluid shunt infection in children. Pediatr Neurosci 15:131–135PubMedCrossRef
18.
Zurück zum Zitat Sciubba DM, Stuart RM, McGirt MJ, Woodworth GF, Samdani A, Carson B, Jallo GI (2005) Effect of antibiotic-impregnated shunt catheters in decreasing the incidence of shunt infection in the treatment of hydrocephalus. J Neurosurg 103:131–136PubMed Sciubba DM, Stuart RM, McGirt MJ, Woodworth GF, Samdani A, Carson B, Jallo GI (2005) Effect of antibiotic-impregnated shunt catheters in decreasing the incidence of shunt infection in the treatment of hydrocephalus. J Neurosurg 103:131–136PubMed
19.
Zurück zum Zitat Sciubba DM, McGirt MJ, Woodworth GF, Carson B, Jallo GI (2007) Prolonged exposure to antibiotic-impregnated shunt catheters does not increase incidence of late shunt infections. Childs Nerv Syst 23:867–871PubMedCrossRef Sciubba DM, McGirt MJ, Woodworth GF, Carson B, Jallo GI (2007) Prolonged exposure to antibiotic-impregnated shunt catheters does not increase incidence of late shunt infections. Childs Nerv Syst 23:867–871PubMedCrossRef
20.
Zurück zum Zitat Shapiro S, Boaz J, Kleiman M, Kalsbeck J, Mealey J (1988) Origin of organisms infecting ventricular shunts. Neurosurgery 22:868–872PubMedCrossRef Shapiro S, Boaz J, Kleiman M, Kalsbeck J, Mealey J (1988) Origin of organisms infecting ventricular shunts. Neurosurgery 22:868–872PubMedCrossRef
21.
Zurück zum Zitat Vanaclocha V, Saiz-Sapena N, Leiva J (1996) Shunt malfunction in relation to shunt infection. Acta Neurochir (Wien) 138:829–834CrossRef Vanaclocha V, Saiz-Sapena N, Leiva J (1996) Shunt malfunction in relation to shunt infection. Acta Neurochir (Wien) 138:829–834CrossRef
22.
Zurück zum Zitat Walters BC, Hoffman HJ, Hendrick EB, Humphreys RP (1984) Cerebrospinal fluid shunt infection. Influences on initial management and subsequent outcome. J Neurosurg 60:1014–1021PubMed Walters BC, Hoffman HJ, Hendrick EB, Humphreys RP (1984) Cerebrospinal fluid shunt infection. Influences on initial management and subsequent outcome. J Neurosurg 60:1014–1021PubMed
23.
Zurück zum Zitat Wang KW, Chang WN, Shih TY, Huang CR, Tsai NW, Chang CS, Chuang YC, Liliang PC, Su TM, Rau CS, Tsai YD, Cheng BC, Hung PL, Chang CJ, Lu CH (2004) Infection of cerebrospinal fluid shunts: causative pathogens, clinical features, and outcomes. Jpn J Infect Dis 57:44–48PubMed Wang KW, Chang WN, Shih TY, Huang CR, Tsai NW, Chang CS, Chuang YC, Liliang PC, Su TM, Rau CS, Tsai YD, Cheng BC, Hung PL, Chang CJ, Lu CH (2004) Infection of cerebrospinal fluid shunts: causative pathogens, clinical features, and outcomes. Jpn J Infect Dis 57:44–48PubMed
24.
Zurück zum Zitat Zabramski JM, Whiting D, Darouiche RO, Horner TG, Olson J, Robertson C, Hamilton AJ (2003) Efficacy of antimicrobial-impregnated external ventricular drain catheters: a prospective, randomized, controlled trial. J Neurosurg 98:725–730PubMedCrossRef Zabramski JM, Whiting D, Darouiche RO, Horner TG, Olson J, Robertson C, Hamilton AJ (2003) Efficacy of antimicrobial-impregnated external ventricular drain catheters: a prospective, randomized, controlled trial. J Neurosurg 98:725–730PubMedCrossRef
Metadaten
Titel
The impact of antibiotic-impregnated catheters on shunt infection in children and neonates
verfasst von
Caroline Hayhurst
Richard Cooke
Dawn Williams
Jothy Kandasamy
Donncha F. O’Brien
Conor L. Mallucci
Publikationsdatum
01.05.2008
Verlag
Springer-Verlag
Erschienen in
Child's Nervous System / Ausgabe 5/2008
Print ISSN: 0256-7040
Elektronische ISSN: 1433-0350
DOI
https://doi.org/10.1007/s00381-007-0521-4

Weitere Artikel der Ausgabe 5/2008

Child's Nervous System 5/2008 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.